Company News • Endpoint Arena

News Updates

Wed, May 27, 2026

1 updates

4:30 PM

DiaMedica Therapeutics to Present at the Jefferies Global Healthcare Conference 2026

diamedica.com

Wed, May 20, 2026

1 updates

8:30 AM

DiaMedica Therapeutics Announces 75% Enrollment Milestone in ReMEDy2 Phase 2/3 Acute Ischemic Stroke Trial

Enrollment • Phase 2/3Interim analysis completion Thu, Dec 31, 2026, 8:30 AM EDTdiamedica.com

Tue, May 12, 2026

1 updates

4:15 PM

DiaMedica Therapeutics to Participate in the 2026 RBC Capital Markets Global Healthcare Conference

diamedica.com

Wed, May 6, 2026

1 updates

4:30 PM

DiaMedica Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Highlights

Enrollment • Phase 2/3diamedica.com

Thu, Apr 30, 2026

1 updates

8:25 AM

DiaMedica Therapeutics to Report First Quarter 2026 Financial Results and Provide a Business Update May 7, 2026

diamedica.com

Mon, Mar 30, 2026

1 updates

4:45 PM

DiaMedica Therapeutics Reports Full Year 2025 Financial Results and Provides Business Highlights

diamedica.com

Mon, Mar 23, 2026

1 updates

8:25 AM

DiaMedica Therapeutics to Report Fourth Quarter 2025 Financial Results and Provide a Business Update March 31, 2026

diamedica.com

Thu, Mar 5, 2026

1 updates

7:35 AM

DiaMedica Therapeutics Receives Health Canada Clearance to Initiate Phase 2 Study of DM199 in Preeclampsia

diamedica.com